SF 6,5: structure given in first source; an Arg-Gly-Asp mimetic; inhibits adhesive interactions between tumor cells and Arg-Gly-Arg (RGD) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 126860 |
| SCHEMBL ID | 3986924 |
| MeSH ID | M0224887 |
| Synonym |
|---|
| 5-((6-((aminomethyl)amino)-1-oxohexyl)amino)pentanoic acid |
| SCHEMBL3986924 |
| 5-[6-(diaminomethylideneamino)hexanoylamino]pentanoic acid |
| pentanoic acid, 5-((6-((aminomethyl)amino)-1-oxohexyl)amino)- |
| sf-6,5 |
| sf 6,5 |
| 145328-92-3 |
| DTXSID70162982 |
| BULXDAAOZVOYBI-UHFFFAOYSA-N , |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.37) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (28.57%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (71.43%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||